RE:RE:RE:RE:RE:RE:RE:RE:March Warrants Boy I am no expert on this FDA process. My understanding, as it is, they probably have a pass on talking about anything that comes out of this process till after they have gotten as far as they can, ie stalled, or approved. In the mean time they can discuss Canada Phase 2 results but it seems they are being extra careful so not to upset any regulators. We could hear results anytime, IMO.
fredgoodwinson wrote: Quattro - on the subject of 'material information' is the reason for the Clinical Hold not price-sensitive and for full disclosure and as a Public Body are such pronouncements by the FDA not publically accessible?